Compounds > eosine yellowish-(ys)
Page last updated: 2024-08-21

eosine yellowish-(ys) and Carcinoma, Transitional Cell

eosine yellowish-(ys) has been researched along with Carcinoma, Transitional Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Braun, V; Brinker, TJ; Fröhling, S; Gaiser, T; Krieghoff-Henning, E; Kuntz, S; Michel, MS; Neuberger, M; Nuhn, P; Schmitt, M; Steeg, M; Wessels, F; Worst, TS1
Glina, S; Korkes, F; Krutman-Zveibil, D; Monteiro, CRA1
Amin, MB; Beach, R; De Peralta-Venturina, MN; Fanger, GR; Folpe, AL; Gown, AM; Grignon, DJ; Salles, PG; Yaziji, H1
Beneforti, P; Bizzoco, E; Faussone-Pellegrini, MS; Lazzeri, M; Spinelli, M; Turini, D; Vannucchi, MG1
Takenaka, I; Zhang, X1

Reviews

1 review(s) available for eosine yellowish-(ys) and Carcinoma, Transitional Cell

ArticleYear
Artificial intelligence to predict oncological outcome directly from hematoxylin and eosin-stained slides in urology.
    Minerva urology and nephrology, 2022, Volume: 74, Issue:5

    Topics: Artificial Intelligence; Carcinoma, Transitional Cell; Eosine Yellowish-(YS); Hematoxylin; Humans; Male; Urinary Bladder Neoplasms; Urology

2022

Other Studies

4 other study(ies) available for eosine yellowish-(ys) and Carcinoma, Transitional Cell

ArticleYear
Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence.
    Einstein (Sao Paulo, Brazil), 2022, Volume: 20

    Topics: Brazil; Carcinoma, Transitional Cell; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Male; Muscles; Mutation; Prevalence; Receptor, Fibroblast Growth Factor, Type 3; RNA; Urinary Bladder Neoplasms

2022
P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
    The American journal of surgical pathology, 2002, Volume: 26, Issue:12

    Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Biopsy, Needle; Carcinoma; Carcinoma, Transitional Cell; Coloring Agents; Cystectomy; Eosine Yellowish-(YS); Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hematoxylin; Humans; Immunohistochemistry; Male; Prospective Studies; Prostate; Prostatectomy; Prostatic Neoplasms; Racemases and Epimerases; Staining and Labeling

2002
Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    European urology, 2005, Volume: 48, Issue:4

    Topics: Aged; Blotting, Western; Carcinoma, Transitional Cell; Case-Control Studies; Coloring Agents; Eosine Yellowish-(YS); Female; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Hematoxylin; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Staining and Labeling; TRPV Cation Channels; Urinary Bladder Neoplasms; Urothelium

2005
Apoptosis and carcinogenesis: morphologic observations in the rat bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    International journal of urology : official journal of the Japanese Urological Association, 1998, Volume: 5, Issue:3

    Topics: Animals; Apoptosis; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Coloring Agents; Eosine Yellowish-(YS); Fluorescent Dyes; Genetic Techniques; Hematoxylin; Male; Microscopy, Electron; Neoplasm Invasiveness; Rats; Rats, Wistar; Staining and Labeling; Urinary Bladder Neoplasms

1998